溶瘤病毒
光动力疗法
癌症研究
肿瘤微环境
溶癌病毒
体内
医学
脑瘤
免疫系统
癌症
病理
生物
免疫学
化学
肿瘤细胞
内科学
有机化学
生物技术
作者
K. Shimizu,Andranik Kahramanian,Muzammil Arif Din Abdul Jabbar,Fatma Turna Demir,Dilan Gokyer,Abicumaran Uthamacumaran,Anant P. Rajan,Mohammad Ahsan Saad,Joshua Gorham,Hiroko Wakimoto,Robert L. Martuza,Samuel D. Rabkin,Tayyaba G. Hasan,Hiroaki Wakimoto
出处
期刊:Cancer Letters
[Elsevier BV]
日期:2023-08-22
卷期号:572: 216363-216363
被引量:24
标识
DOI:10.1016/j.canlet.2023.216363
摘要
Oncolytic viruses (OVs) have emerged as a clinical therapeutic modality potentially effective for cancers that evade conventional therapies, including central nervous system malignancies. Rationally designed combinatorial strategies can augment the efficacy of OVs by boosting tumor-selective cytotoxicity and modulating the tumor microenvironment (TME). Photodynamic therapy (PDT) of cancer not only mediates direct neoplastic cell death but also primes the TME to sensitize the tumor to secondary therapies, allowing for the combination of two potentially synergistic therapies with broader targets. Here, we created G47Δ-KR, clinical oncolytic herpes simplex virus G47Δ that expresses photosensitizer protein KillerRed (KR). Optical properties and cytotoxic effects of G47Δ-KR infection followed by amber LED illumination (peak wavelength: 585-595 nm) were examined in human glioblastoma (GBM) and malignant meningioma (MM) models in vitro. G47Δ-KR infection of tumor cells mediated KR expression that was activated by LED and produced reactive oxygen species, leading to cell death that was more robust than G47Δ-KR without light. In vivo, we tested photodynamic-oncolytic virus (PD-OV) therapy employing intratumoral injection of G47Δ-KR followed by laser light tumor irradiation (wavelength: 585 nm) in GBM and MM xenografts. PD-OV therapy was feasible in these models and resulted in potent anti-tumor effects that were superior to G47Δ-KR alone (without laser light) or laser light alone. RNA sequencing analysis of post-treatment tumor samples revealed PD-OV therapy-induced increases in TME infiltration of variable immune cell types. This study thus demonstrated the proof-of-concept that G47Δ-KR enables PD-OV therapy for neuro-oncological malignancies and warrants further research to advance potential clinical translation.
科研通智能强力驱动
Strongly Powered by AbleSci AI